REFERENCES
- Andersen, M.E., R.S.H. Yang, H.J. Clewell III, and M.B. Reddy: Physiologically Based Pharmacokinetic Modeling. Science and Applications. New York: Wiley-Interscience, 2005.
- Andersen, M.E.: Toxicokinetic modeling and its applications in chemical risk assessment. Toxicol. Lett. 138:9–27 (2003).
- Fiserova-Bergerova, V.: Mathematical modelling of inhalation exposure. J. Combustion Toxicol. 3:201–210 (1976).
- Fiserova-Bergerova, V., J. Vlach, and J.C. Cassady: Predictable “individual differences” in uptake and excretion of gases and lipid soluble vapors simulation study. Br. J. Ind. Med. 37:42–49 (1980).
- Fiserova-Bergerova, V.: Toxicokinetics of organic solvents. Scand. J. Work Environ. Health 11(1):7–21 (1985).
- Bernillon, P., and F.Y. Bois: Statistical issues in toxicokinetic modeling: A Bayesian perspective. Environ. Health Persp. 108(5):883–893 (2000).
- Droz, P.-O., M.M. Wu, and W.G. Cumberland: Variability in biological monitoring of solvent exposure. I. Development of a population physiological model. Br. J. Ind. Med. 46:447–460 (1989).
- Pierrehumbert, G., P.-O. Droz, R. Tardif, G. Charest-Tardif, and G. Truchon: Impact of human variability on the biological monitoring of exposure to toluene, phenol, lead, and mercury. II. Compartmental based toxicokinetic modelling. Toxicol. Lett. 134:165–173 (2002).
- Truchon, G., R. Tardif, P.-O. Droz, G. Charest-Tardif, and G. Pierrehumbert: Biological exposure indicators: Quantification of biological variability using toxicokinetic modeling. J. Occup. Environ. Hyg. 3(3):137–143 (2006).
- Berthet, A., A.deBatz, R. Tardif, et al.: Impact of biological and environmental variabilities on biological monitoring—An approach using toxicokinetic models. J. Occup. Environ. Hyg. 7(3):177–184 (2010).
- Clewell, H.J., P.R. Gentry, T.R. Covington, R. Sarangapani, and J.G. Teeguarden: Evaluation of the potential impact of age- and sex-specific pharmacokinetic differences on tissue dosimetry. Toxicol. Sci. 79:381–393 (2004).
- Löf, A., and G. Johanson: Toxicokinetics of organic solvents: A review of modifying factors. Crit. Rev. Toxicol. 28(6):571–650 (1998).
- Gochfeld, M.: Framework for gender differences in human and animal toxicology. Environ. Res. 104(1):4–21 (2007).
- Tomicic, C., M. Berode, A. Oppliger, et al.: Sex differences in urinary levels of several biological indicators of exposure: A human volunteer study. Toxicol. Lett. 202(3):218–225 (2010).
- Reitz, R.H., J.N. McDougal, M.W. Himmelstein, R.J. Nola, and A.M. Schumann: Physiologically based pharmacokinetic modeling with methylchloroform: Implications for interspecies, high dose/low dose, and dose route extrapolations. Toxicol. Appl. Pharm. 95(2):185–199 (1988).
- Fiserova-Bergerova, V.: Extrapolation of physiological parameters for physiologically based simulation models. Toxicol. Lett. 79:77–86 (1995).
- Thomas, R.S., P.L. Bigelow, T.J. Keefe, and R.S.H. Yang: Variability in biological exposure indices using physiologically based pharmacokinetic modeling and Monte Carlo simulation. Am. Ind. Hyg. Assoc. J. 57(1):23–32 (1996).
- Laparé, S., R. Tardif, and J. Brodeur: Effect of various exposure scenarios on the biological monitoring of organic solvents in alveolar air II. 1-1-1-trichloroethane and trichloroethylene. Int. Arch. Occup. Environ. Health 67:375–394 (1995).
- Liira, J., V. Riihimaki, and P. Pfaffli: Kinetics of methyl ethyl ketone in man: Absorption, distribution and elimination in inhalation exposure. Int. Arch. Occup. Environ. Health 60(3):195–200 (1988).
- Thrall, K.D., J.J. Soelberg, K.K. Weitz, and A.D. Woodstock: Development of a physiologically based pharmacokinetic model for methyl ethyl ketone in F344 rats. J. Toxicol. Env. Health 65(13):881–896 (2002).
- Devanthéry, A.: Toxico-cinétique et surveillance biologique du propylène glycol monométhyl éther. Etude sur des volontaires. Unpublished Ph.D. thesis. Federal Polytechnic School of Lausanne, Switzerland (2003).
- Johanson, G., and B. Dynésius: Liquid/air partition coefficients of six commonly used glycol ethers. Br. J. Ind. Med. 45(8):561–564 (1988).
- Corley, R.A., R.A. Gies, H. Wu, and K.K. Weitz: Development of a physiologically based pharmacokinetic model for propylene glycol monomethyl ether and its acetate in rats and humans. Toxicol. Lett. 156:193–213 (2005).
- Nolan, R.J., N.L. Freshour, D.L. Rich, L.P. McCarty, and J.H. Saunders: Kinetics and metabolism of inhaled methyl chloroform (1,1,1-trichloroethane) in male volunteers. Fundam. Appl. Toxicol. 4:654–662 (1984).
- Tardif, R., G. Charest-Tardif, J. Brodeur, and K. Krishnan: Physiologically based pharmacokinetic modeling of a ternary mixture alkyl benzenes in rats and humans. Toxicol. Appl. Pharm. 144(1):120–134 (1997).
- Caperos, J.R., P.-O. Droz, C.L. Hake, B.E. Humbert, and A. Jacot-Guillarmod: 1,1,1-trichloroethane exposure, biologic monitoring by breath and urine analyses. Int. Arch. Occup. Environ. Health 49(3–4):293–303 (1982).
- Miners, J.O., J. Attwood, and D.J. Birkett: Influence of sex and oral contraceptive steroids on paracetamol metabolism. Br. J. Clin. Pharmacol. 16(5):503–509 (1983).
- Sari-Minodier, I., G. Truchon, G. Charest-Tardif, A. Bérubé, and R. Tardif: The effect of workload on biological monitoring of occupational exposure to toluene and N-hexane: Contribution of physiologically based toxicokinetic modeling. J. Occup. Environ. Hyg. 6(7):415–432 (2009).
- Liira, J., G. Johanson, and V. Riihimaki: Dose-dependent kinetics of inhaled methylethylketone in man. Toxicol. Lett. 50(2–3):195–201 (1990).